TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs10047462
log Bayes Factor = 2.4031
Chromosome 11   position 116,722,041  (GRCh37) Explore rs10047462 on Ensembl!
Variant rs10047462 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
E78.0 Pure hypercholesterolaemia
0.000 0.004 0.996
E78 Disorders of lipoprotein metabolism and other lipidaemias
0.000 0.115 0.885
E78.5 Hyperlipidaemia, unspecified
0.000 0.131 0.869
E78.2 Mixed hyperlipidaemia
0.000 0.257 0.742
E78.1 Pure hyperglyceridaemia
0.000 0.350 0.650
E78.9 Disorder of lipoprotein metabolism, unspecified
0.000 0.375 0.625
E78.3 Hyperchylomicronaemia
0.000 0.387 0.613
E78.6 Lipoprotein deficiency
0.000 0.435 0.564
E78.8 Other disorders of lipoprotein metabolism
0.000 0.439 0.560
E78.4 Other hyperlipidaemia
0.000 0.445 0.555
H26.9 Cataract, unspecified
0.000 0.930 0.070
I10 Essential (primary) hypertension
0.000 0.970 0.030
M16.1 Other primary coxarthrosis
0.029 0.971 0.000
M16.9 Coxarthrosis, unspecified
0.029 0.971 0.000
M16 Coxarthrosis [arthrosis of hip]
0.028 0.972 0.000
M16.7 Other secondary coxarthrosis
0.023 0.977 0.000
M16.0 Primary coxarthrosis, bilateral
0.023 0.977 0.000
M16.5 Other posttraumatic coxarthrosis
0.023 0.977 0.000
M16.4 Posttraumatic coxarthrosis, bilateral
0.020 0.979 0.000
M16.2 Coxarthrosis resulting from dysplasia, bilateral
0.019 0.980 0.000
M16.3 Other dysplastic coxarthrosis
0.019 0.981 0.000
I71.4 Abdominal aortic aneurysm, without mention of rupture
0.000 0.981 0.019
M16.6 Other secondary coxarthrosis, bilateral
0.019 0.981 0.000
I74 Arterial embolism and thrombosis
0.000 0.981 0.019
I71 Aortic aneurysm and dissection
0.000 0.981 0.019
I74.2 Embolism and thrombosis of arteries of the upper extremities
0.000 0.981 0.019
I71.9 Aortic aneurysm of unspecified site, without mention of rupture
0.000 0.981 0.019
H26 Other cataract
0.000 0.982 0.018
I74.5 Embolism and thrombosis of iliac artery
0.000 0.983 0.017
I74.0 Embolism and thrombosis of abdominal aorta
0.000 0.984 0.016
I70-I79 Diseases of arteries, arterioles and capillaries
0.000 0.984 0.016
I74.8 Embolism and thrombosis of other arteries
0.000 0.985 0.015
I71.0 Dissection of aorta [any part]
0.000 0.985 0.015
H26.0 Infantile, juvenile and presenile cataract
0.000 0.985 0.015
I74.4 Embolism and thrombosis of arteries of extremities, unspecified
0.000 0.986 0.014
H26.3 Drug-induced cataract
0.000 0.986 0.014
I71.8 Aortic aneurysm of unspecified site, ruptured
0.000 0.986 0.013
I71.5 Thoracoabdominal aortic aneurysm, ruptured
0.000 0.986 0.013
I74.9 Embolism and thrombosis of unspecified artery
0.000 0.986 0.013
I70 Atherosclerosis
0.000 0.986 0.014
I71.6 Thoracoabdominal aortic aneurysm, without mention of rupture
0.000 0.987 0.013
I74.1 Embolism and thrombosis of other and unspecified parts of aorta
0.000 0.987 0.013
I71.2 Thoracic aortic aneurysm, without mention of rupture
0.000 0.987 0.013
I71.1 Thoracic aortic aneurysm, ruptured
0.000 0.987 0.013
I72 Other aneurysm
0.000 0.987 0.013
H26.1 Traumatic cataract
0.000 0.988 0.012
H26.4 After-cataract
0.000 0.988 0.012
I74.3 Embolism and thrombosis of arteries of the lower extremities
0.000 0.988 0.012
I71.3 Abdominal aortic aneurysm, ruptured
0.000 0.988 0.012
I70.2 Atherosclerosis of arteries of the extremities
0.000 0.989 0.011
I78 Diseases of capillaries
0.000 0.989 0.011
I70.0 Atherosclerosis of aorta
0.000 0.989 0.011
I70.8 Atherosclerosis of other arteries
0.000 0.989 0.010
I72.8 Aneurysm of other specified arteries
0.000 0.989 0.010
I78.0 Hereditary haemorrhagic telangiectasia
0.000 0.990 0.010
I70.20 Atherosclerosis of arteries of extremities (without gangrene)
0.000 0.990 0.010
N94.8 Other specified conditions associated with female genital organs and menstrual cycle
0.000 0.990 0.010
I72.1 Aneurysm of artery of upper extremity
0.000 0.990 0.010
E70-E90 Metabolic disorders
0.000 0.990 0.010
I72.0 Aneurysm of carotid artery
0.000 0.990 0.010
I70.1 Atherosclerosis of renal artery
0.000 0.990 0.010
H26.8 Other specified cataract
0.000 0.990 0.010
I70.9 Generalised and unspecified atherosclerosis
0.000 0.990 0.010
I72.4 Aneurysm of artery of lower extremity
0.000 0.990 0.010
I72.5 Aneurysm and dissection of other precerebral arteries
0.000 0.990 0.009
J69.0 Pneumonitis due to food and vomit
0.009 0.991 0.000
I79 Disorders of arteries, arterioles and capillaries in diseases classified elsewhere
0.000 0.991 0.009
I72.6 Aneurysm and dissection of vertebral artery
0.000 0.991 0.009
H26.2 Complicated cataract
0.000 0.991 0.009
E75 Disorders of sphingolipid metabolism and other lipid storage disorders
0.000 0.991 0.009
I70.00 Atherosclerosis of aorta (without gangrene)
0.000 0.991 0.009
I78.8 Other diseases of capillaries
0.000 0.991 0.009
I72.3 Aneurysm of iliac artery
0.000 0.991 0.008
I72.9 Aneurysm of unspecified site
0.000 0.992 0.008
I70.80 Atherosclerosis of other arteries (without gangrene)
0.000 0.992 0.008
E72 Other disorders of amino-acid metabolism
0.000 0.992 0.008
E80 Disorders of porphyrin and bilirubin metabolism
0.000 0.992 0.008
G93.3 Postviral fatigue syndrome
0.000 0.992 0.008
O47.1 False labour at or after 37 completed weeks of gestation
0.000 0.992 0.008
I78.9 Disease of capillaries, unspecified
0.000 0.992 0.008
J61 Pneumoconiosis due to asbestos and other mineral fibres
0.008 0.992 0.000
E84 Cystic fibrosis
0.000 0.992 0.008
I70.01 Atherosclerosis of aorta (with gangrene)
0.000 0.992 0.008
I72.2 Aneurysm of renal artery
0.000 0.992 0.008
E80.4 Gilbert's syndrome
0.000 0.992 0.008
E75.5 Other lipid storage disorders
0.000 0.992 0.008
I70.81 Atherosclerosis of other arteries (with gangrene)
0.000 0.992 0.008
E70 Disorders of aromatic amino-acid metabolism
0.000 0.992 0.008
J69 Pneumonitis due to solids and liquids
0.008 0.992 0.000
E76 Disorders of glycosaminoglycan metabolism
0.000 0.992 0.007
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
0.000 0.992 0.007
E90 Nutritional and metabolic disorders in diseases classified elsewhere
0.000 0.992 0.007
E77 Disorders of glycoprotein metabolism
0.000 0.992 0.007
I70.11 Atherosclerosis of renal artery (with gangrene)
0.000 0.993 0.007
I70.10 Atherosclerosis of renal artery (without gangrene)
0.000 0.993 0.007
I70.91 Generalized and unspecified atherosclerosis (with gangrene)
0.000 0.993 0.007
I70.21 Atherosclerosis of arteries of extremities (with gangrene)
0.000 0.993 0.007
I70.90 Generalized and unspecified atherosclerosis (without gangrene)
0.000 0.993 0.007
E79 Disorders of purine and pyrimidine metabolism
0.000 0.993 0.007
E72.0 Disorders of amino-acid transport
0.000 0.993 0.007
I79.1 Aortitis in diseases classified elsewhere
0.000 0.993 0.007
I79.0 Aneurysm of aorta in diseases classified elsewhere
0.000 0.993 0.007
E75.2 Other sphingolipidosis
0.000 0.993 0.007
J60-J70 Lung diseases due to external agents
0.007 0.993 0.000
E74 Other disorders of carbohydrate metabolism
0.000 0.993 0.007
S92.00 Fracture of calcaneus (closed)
0.000 0.993 0.007
E75.6 Lipid storage disorder, unspecified
0.000 0.993 0.007
E75.4 Neuronal ceroid lipofuscinosis
0.000 0.993 0.007
E75.3 Sphingolipidosis, unspecified
0.000 0.993 0.007
E75.1 Other gangliosidosis
0.000 0.993 0.007
E75.0 GM2 gangliosidosis
0.000 0.993 0.007
I79.8 Other disorders of arteries, arterioles and capillaries in diseases classified elsewhere
0.000 0.993 0.006
E80.1 Porphyria cutanea tarda
0.000 0.993 0.006
E84.9 Cystic fibrosis, unspecified
0.000 0.993 0.006
E72.1 Disorders of sulphur-bearing amino-acid metabolism
0.000 0.994 0.006
E73 Lactose intolerance
0.000 0.994 0.006
E72.9 Disorder of amino-acid metabolism, unspecified
0.000 0.994 0.006
E72.8 Other specified disorders of amino-acid metabolism
0.000 0.994 0.006
E72.5 Disorders of glycine metabolism
0.000 0.994 0.006
E72.4 Disorders of ornithine metabolism
0.000 0.994 0.006
E72.3 Disorders of lysine and hydroxylysine metabolism
0.000 0.994 0.006
E72.2 Disorders of urea cycle metabolism
0.000 0.994 0.006
H25-H28 Disorders of lens
0.000 0.994 0.006
E80.5 Crigler-Najjar syndrome
0.000 0.994 0.006
E80.3 Defects of catalase and peroxydase
0.000 0.994 0.006
E80.0 Hereditary erythropoietic porphyria
0.000 0.994 0.006
E84.0 Cystic fibrosis with pulmonary manifestations
0.000 0.994 0.006
E84.8 Cystic fibrosis with other manifestations
0.000 0.994 0.006
E84.1 Cystic fibrosis with intestinal manifestations
0.000 0.994 0.006
E88 Other metabolic disorders
0.000 0.994 0.006
E70.3 Albinism
0.000 0.994 0.006
Z08.7 Follow-up examination after combined treatment for malignant neoplasm
0.000 0.994 0.006
N85.8 Other specified noninflammatory disorders of uterus
0.000 0.994 0.006
E80.7 Disorder of bilirubin metabolism, unspecified
0.000 0.994 0.006
E70.9 Disorder of aromatic amino-acid metabolism, unspecified
0.000 0.994 0.006
E70.8 Other disorders of aromatic amino-acid metabolism
0.000 0.994 0.006
E70.2 Disorders of tyrosine metabolism
0.000 0.994 0.006
E70.1 Other hyperphenylalaninaemias
0.000 0.994 0.006
E70.0 Classical phenylketonuria
0.000 0.994 0.006
I77 Other disorders of arteries and arterioles
0.000 0.994 0.006
J69.1 Pneumonitis due to oils and essences
0.006 0.994 0.000
J64 Unspecified pneumoconiosis
0.006 0.994 0.000
E71.3 Disorders of fatty-acid metabolism
0.000 0.994 0.005
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified
0.000 0.994 0.005
E71.1 Other disorders of branched-chain amino-acid metabolism
0.000 0.994 0.005
E71.0 Maple-syrup-urine disease
0.000 0.994 0.005
E76.9 Disorder of glucosaminoglycan metabolism, unspecified
0.000 0.994 0.005
E76.8 Other disorders of glucosaminoglycan metabolism
0.000 0.994 0.005
E76.3 Mucopolysaccharidosis, unspecified
0.000 0.994 0.005
E76.2 Other mucopolysaccharidoses
0.000 0.994 0.005
E76.1 Mucopolysaccharidosis, type II
0.000 0.994 0.005
E76.0 Mucopolysaccharidosis, type I
0.000 0.994 0.005
E77.9 Disorder of glycoprotein metabolism, unspecified
0.000 0.994 0.005
E77.1 Defects in glycoprotein degradation
0.000 0.994 0.005
E77.0 Defects in posttranslational modification of lysosomal enzymes
0.000 0.994 0.005
E80.2 Other porphyria
0.000 0.994 0.005
E77.8 Other disorders of glycoprotein metabolism
0.000 0.994 0.005
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified
0.000 0.994 0.006
I79.2 Peripheral angiopathy in diseases classified elsewhere
0.000 0.994 0.005
I73 Other peripheral vascular diseases
0.000 0.994 0.006
E85 Amyloidosis
0.000 0.994 0.005
E79.9 Disorder of purine and pyrimidine metabolism, unspecified
0.000 0.995 0.005
E79.8 Other disorders of purine and pyrimidine metabolism
0.000 0.995 0.005
E79.1 Lesch-Nyhan syndrome
0.000 0.995 0.005
E80.6 Other disorders of bilirubin metabolism
0.000 0.995 0.005
J60 Coalworker's pneumoconiosis
0.005 0.995 0.000
J70 Respiratory conditions due to other external agents
0.005 0.995 0.000
J68 Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours
0.005 0.995 0.000
J66 Airway disease due to specific organic dust
0.005 0.995 0.000
J63 Pneumoconiosis due to other inorganic dusts
0.005 0.995 0.000
J65 Pneumoconiosis associated with tuberculosis
0.005 0.995 0.000
E74.9 Disorder of carbohydrate metabolism, unspecified
0.000 0.995 0.005
E74.8 Other specified disorders of carbohydrate metabolism
0.000 0.995 0.005
E74.4 Disorders of pyruvate metabolism and gluconeogenesis
0.000 0.995 0.005
E74.2 Disorders of galactose metabolism
0.000 0.995 0.005
E74.1 Disorders of fructose metabolism
0.000 0.995 0.005
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease
0.000 0.995 0.005
J69.8 Pneumonitis due to other solids and liquids
0.005 0.995 0.000
J62 Pneumoconiosis due to dust containing silica
0.005 0.995 0.000
E89.2 Postprocedural hypoparathyroidism
0.000 0.995 0.005
H27 Other disorders of lens
0.000 0.995 0.005
E74.3 Other disorders of intestinal carbohydrate absorption
0.000 0.995 0.005
E74.0 Glycogen storage disease
0.000 0.995 0.005
E73.8 Other lactose intolerance
0.000 0.995 0.005
E73.1 Secondary lactase deficiency
0.000 0.995 0.005
E73.0 Congenital lactase deficiency
0.000 0.995 0.005
I77.3 Arterial fibromuscular dysplasia
0.000 0.995 0.005
J67 Hypersensitivity pneumonitis due to organic dust
0.005 0.995 0.000
H28 Cataract and other disorders of lens in diseases classified elsewhere
0.000 0.995 0.005
E88.3 Tumour lysis syndrome
0.000 0.995 0.005
I77.8 Other specified disorders of arteries and arterioles
0.000 0.995 0.005
E88.1 Lipodystrophy, not elsewhere classified
0.000 0.995 0.004
E88.2 Lipomatosis, not elsewhere classified
0.000 0.995 0.004
I77.5 Necrosis of artery
0.000 0.995 0.004
I77.4 Coeliac artery compression syndrome
0.000 0.995 0.004
E88.9 Metabolic disorder, unspecified
0.000 0.996 0.004
E88.8 Other specified metabolic disorders
0.000 0.996 0.004
E89.1 Postprocedural hypoinsulinaemia
0.000 0.996 0.004
H27.1 Dislocation of lens
0.000 0.996 0.004
R19.0 Intra-abdominal and pelvic swelling, mass and lump
0.004 0.996 0.000
I77.0 Arteriovenous fistula, acquired
0.000 0.996 0.004
E89.5 Postprocedural testicular hypofunction
0.000 0.996 0.004
E89.9 Postprocedural endocrine and metabolic disorder, unspecified
0.000 0.996 0.004
I73.1 Thromboangiitis obliterans [Buerger]
0.000 0.996 0.004
J70.0 Acute pulmonary manifestations due to radiation
0.004 0.996 0.000
E85.2 Heredofamilial amyloidosis, unspecified
0.000 0.996 0.004
E85.1 Neuropathic heredofamilial amyloidosis
0.000 0.996 0.004
E85.0 Nonneuropathic heredofamilial amyloidosis
0.000 0.996 0.004
E85.8 Other amyloidosis
0.000 0.996 0.004
E89.6 Postprocedural adrenocortical(-medullary) hypofunction
0.000 0.996 0.004
E89.8 Other postprocedural endocrine and metabolic disorders
0.000 0.996 0.004
I77.2 Rupture of artery
0.000 0.996 0.004
E89.4 Postprocedural ovarian failure
0.000 0.996 0.004
J70.1 Chronic and other pulmonary manifestations due to radiation
0.004 0.996 0.000
J70.9 Respiratory conditions due to unspecified external agent
0.004 0.996 0.000
J70.8 Respiratory conditions due to other specified external agents
0.004 0.996 0.000
J70.3 Chronic drug-induced interstitial lung disorders
0.004 0.996 0.000
J70.2 Acute drug-induced interstitial lung disorders
0.004 0.996 0.000
O68.1 Labour and delivery complicated by meconium in amniotic fluid
0.004 0.996 0.000
J63.8 Pneumoconiosis due to other specified inorganic dusts
0.004 0.996 0.000
J63.5 Stannosis
0.004 0.996 0.000
J63.4 Siderosis
0.004 0.996 0.000
J63.3 Graphite fibrosis (of lung)
0.004 0.996 0.000
J63.2 Berylliosis
0.004 0.996 0.000
J63.1 Bauxite fibrosis (of lung)
0.004 0.996 0.000
J63.0 Aluminosis (of lung)
0.004 0.996 0.000
J66.8 Airway disease due to other specific organic dusts
0.004 0.996 0.000
J66.2 Cannabinosis
0.004 0.996 0.000
J66.1 Flax-dresser's disease
0.004 0.996 0.000
J66.0 Byssinosis
0.004 0.996 0.000
J68.9 Unspecified respiratory condition due to chemicals, gases, fumes and vapours
0.004 0.996 0.000
J68.8 Other respiratory conditions due to chemicals, gases, fumes and vapours
0.004 0.996 0.000
J68.4 Chronic respiratory conditions due to chemicals, gases, fumes and vapours
0.004 0.996 0.000
J68.3 Other acute and subacute respiratory conditions due to chemicals, gases, fumes and vapours
0.004 0.996 0.000
J68.2 Upper respiratory inflammation due to chemicals, gases, fumes and vapours, not elsewhere classified
0.004 0.996 0.000
J68.1 Acute pulmonary oedema due to chemicals, gases, fumes and vapours
0.004 0.996 0.000
J68.0 Bronchitis and pneumonitis due to chemicals, gases, fumes and vapours
0.004 0.996 0.000
S92.0 Fracture of calcaneus
0.000 0.996 0.004
J70.4 Drug-induced interstitial lung disorder, unspecified
0.004 0.996 0.000
J62.0 Pneumoconiosis due to talc dust
0.004 0.996 0.000
J67.2 Bird fancier's lung
0.004 0.996 0.000
J67.8 Hypersensitivity pneumonitis due to other organic dusts
0.004 0.996 0.000
H27.9 Disorder of lens, unspecified
0.000 0.996 0.004
I77.1 Stricture of artery
0.000 0.996 0.004
E85.3 Secondary systemic amyloidosis
0.000 0.996 0.003
I10-I15 Hypertensive diseases
0.000 0.996 0.004
I73.8 Other specified peripheral vascular diseases
0.000 0.996 0.004
O47 False labour
0.000 0.996 0.004
J67.7 Air-conditioner and humidifier lung
0.003 0.996 0.000
J67.6 Maple-bark-stripper's lung
0.003 0.996 0.000
J67.5 Mushroom-worker's lung
0.003 0.996 0.000
J67.4 Maltworker's lung
0.003 0.996 0.000
J67.3 Suberosis
0.003 0.996 0.000
J67.1 Bagassosis
0.003 0.996 0.000
J67.0 Farmer's lung
0.003 0.996 0.000
J62.8 Pneumoconiosis due to other dust containing silica
0.003 0.996 0.000
E85.4 Organ-limited amyloidosis
0.000 0.996 0.003
H27.8 Other specified disorders of lens
0.000 0.996 0.004
H28.8 Other disorders of lens in diseases classified elsewhere
0.000 0.996 0.003
H28.2 Cataract in other diseases classified elsewhere
0.000 0.996 0.003
H28.1 Cataract in other endocrine, nutritional and metabolic diseases
0.000 0.996 0.003
E73.9 Lactose intolerance, unspecified
0.000 0.996 0.003
H28.0 Diabetic cataract
0.000 0.996 0.003
E85.9 Amyloidosis, unspecified
0.000 0.996 0.003
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.004 0.996 0.000
T42.4 Benzodiazepines
0.004 0.996 0.000
E89.3 Postprocedural hypopituitarism
0.000 0.996 0.003
H25 Senile cataract
0.000 0.996 0.004
H27.0 Aphakia
0.000 0.996 0.003
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified
0.000 0.997 0.003
H25.1 Senile nuclear cataract
0.000 0.997 0.003
S32.50 Fracture of pubis (closed)
0.000 0.997 0.003
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.003 0.997 0.000
S92.01 Fracture of calcaneus (open)
0.000 0.997 0.003
I84.9 Unspecified haemorrhoids without complication
0.000 0.997 0.003
N39.3 Stress incontinence
0.003 0.997 0.000
T50.9 Other and unspecified drugs, medicaments and biological substances
0.003 0.997 0.000
Z08.2 Follow-up examination after chemotherapy for malignant neoplasm
0.000 0.997 0.003
I13 Hypertensive heart and renal disease
0.000 0.997 0.003
C45.0 Mesothelioma of pleura
0.003 0.997 0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.003 0.997 0.000
T93.3 Sequelae of dislocation, sprain and strain of lower limb
0.000 0.997 0.003
O47.9 False labour, unspecified
0.000 0.997 0.003
Z08 Follow-up examination after treatment for malignant neoplasm
0.000 0.997 0.003
T42.0 Hydantoin derivatives
0.003 0.997 0.000
T81.3 Disruption of operation wound, not elsewhere classified
0.003 0.997 0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.003 0.997 0.000
I77.9 Disorder of arteries and arterioles, unspecified
0.000 0.997 0.003
I78.1 Naevus, nonneoplastic
0.000 0.997 0.002
J67.9 Hypersensitivity pneumonitis due to unspecified organic dust
0.002 0.997 0.001
I73.0 Raynaud's syndrome
0.000 0.997 0.003
L72.0 Epidermal cyst
0.003 0.997 0.000
H25.2 Senile cataract, morgagnian type
0.000 0.997 0.003
I77.6 Arteritis, unspecified
0.000 0.997 0.003
C45 Mesothelioma
0.003 0.997 0.000
G93.1 Anoxic brain damage, not elsewhere classified
0.000 0.997 0.003
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.003 0.997 0.000
T42.5 Mixed antiepileptics, not elsewhere classified
0.003 0.997 0.000
T42.2 Succinimides and oxazolidinediones
0.003 0.997 0.000
C45.9 Mesothelioma, unspecified
0.003 0.997 0.000
S30.9 Superficial injury of abdomen, lower back and pelvis, part unspecified
0.000 0.997 0.003
I13.9 Hypertensive heart and renal disease, unspecified
0.000 0.997 0.002
S30.8 Other superficial injuries of abdomen, lower back and pelvis
0.000 0.997 0.003
T42.3 Barbiturates
0.003 0.997 0.000
I11 Hypertensive heart disease
0.000 0.997 0.002
H25.0 Senile incipient cataract
0.000 0.997 0.003
T43.0 Tricyclic and tetracyclic antidepressants
0.003 0.997 0.000
Z08.0 Follow-up examination after surgery for malignant neoplasm
0.000 0.997 0.003
G93 Other disorders of brain
0.000 0.997 0.003
M89.97 Disorder of bone, unspecified (Ankle and foot)
0.003 0.997 0.000
C45.7 Mesothelioma of other sites
0.003 0.997 0.000
Q23.1 Congenital insufficiency of aortic valve
0.003 0.997 0.000
S32.5 Fracture of pubis
0.000 0.997 0.003
T50.4 Drugs affecting uric acid metabolism
0.002 0.997 0.000
S30 Superficial injury of abdomen, lower back and pelvis
0.000 0.997 0.003
I13.1 Hypertensive heart and renal disease with renal failure
0.000 0.997 0.002
K35.0 Acute appendicitis with generalised peritonitis
0.003 0.997 0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.003 0.997 0.000
I13.0 Hypertensive heart and renal disease with (congestive) heart failure
0.000 0.997 0.002
H02.9 Disorder of eyelid, unspecified
0.000 0.997 0.003
F33.9 Recurrent depressive disorder, unspecified
0.002 0.997 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.002 0.998 0.000
O34.7 Maternal care for abnormality of vulva and perineum
0.000 0.998 0.002
T50.1 Loop [high-ceiling] diuretics
0.002 0.998 0.000
D68.2 Hereditary deficiency of other clotting factors
0.002 0.998 0.000
F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms
0.002 0.998 0.000
I13.2 Hypertensive heart and renal disease with both (congestive) heart failure and renal failure
0.000 0.998 0.002
K55.1 Chronic vascular disorders of intestine
0.000 0.998 0.002
O47.0 False labour before 37 completed weeks of gestation
0.000 0.998 0.002
O36.0 Maternal care for rhesus isoimmunisation
0.000 0.998 0.002
T36-T50 Poisoning by drugs, medicaments and biological substances
0.002 0.998 0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.002 0.998 0.000
Y45.0 Opioids and related analgesics
0.002 0.998 0.000
O35.8 Maternal care for other (suspected) foetal abnormality and damage
0.000 0.998 0.002
T50.7 Analeptics and opioid receptor antagonists
0.002 0.998 0.000
T50.5 Appetite depressants
0.002 0.998 0.000
T50.3 Electrolytic, caloric and water-balance agents
0.002 0.998 0.000
T50.0 Mineralocorticoids and their antagonists
0.002 0.998 0.000
S30.0 Contusion of lower back and pelvis
0.000 0.998 0.002
T50.8 Diagnostic agents
0.002 0.998 0.000
K55.2 Angiodysplasia of colon
0.000 0.998 0.002
Z08.1 Follow-up examination after radiotherapy for malignant neoplasm
0.000 0.998 0.002
Z45.8 Adjustment and management of other implanted devices
0.000 0.998 0.002
C45.2 Mesothelioma of pericardium
0.002 0.998 0.000
I73.9 Peripheral vascular disease, unspecified
0.000 0.998 0.002
G93.8 Other specified disorders of brain
0.000 0.998 0.002
T42.1 Iminostilbenes
0.002 0.998 0.000
T50.6 Antidotes and chelating agents, not elsewhere classified
0.002 0.998 0.000
F33 Recurrent depressive disorder
0.002 0.998 0.000
G93.2 Benign intracranial hypertension
0.000 0.998 0.002
G93.7 Reye's syndrome
0.000 0.998 0.002
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.002 0.998 0.000
I15 Secondary hypertension
0.001 0.998 0.002
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.002 0.998 0.000
S30.7 Multiple superficial injuries of abdomen, lower back and pelvis
0.000 0.998 0.002
S32.51 Fracture of pubis (open)
0.000 0.998 0.002
Q23 Congenital malformations of aortic and mitral valves
0.002 0.998 0.000
C45.1 Mesothelioma of peritoneum
0.002 0.998 0.000
X23.9 Unspecified place
0.000 0.998 0.002
M35.0 Sicca syndrome [Sjogren]
0.000 0.998 0.002
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.002 0.998 0.000
Q21.1 Atrial septal defect
0.002 0.998 0.000
O35 Maternal care for known or suspected foetal abnormality and damage
0.000 0.998 0.002
I11.0 Hypertensive heart disease with (congestive) heart failure
0.000 0.998 0.002
F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms
0.002 0.998 0.000
K55.0 Acute vascular disorders of intestine
0.000 0.998 0.002
S30.2 Contusion of external genital organs
0.000 0.998 0.002
M89.9 Disorder of bone, unspecified
0.002 0.998 0.000
S30.1 Contusion of abdominal wall
0.000 0.998 0.002
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.002 0.998 0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.002 0.998 0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.002 0.998 0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.002 0.998 0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.002 0.998 0.000
T44.1 Other parasympathomimetics [cholinergics]
0.002 0.998 0.000
T44.0 Anticholinesterase agents
0.002 0.998 0.000
H60.9 Otitis externa, unspecified
0.000 0.998 0.002
O35.1 Maternal care for (suspected) chromosomal abnormality in foetus
0.000 0.998 0.002
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.002 0.998 0.000
I11.9 Hypertensive heart disease without (congestive) heart failure
0.000 0.998 0.002
K12.3 Oral mucositis (ulcerative)
0.000 0.998 0.002
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.002 0.998 0.000
T45.5 Anticoagulants
0.002 0.998 0.000
M89.55 Osteolysis (Pelvic region and thigh)
0.002 0.998 0.000
N94.4 Primary dysmenorrhoea
0.000 0.998 0.002
R04.0 Epistaxis
0.000 0.998 0.002
K55 Vascular disorders of intestine
0.000 0.998 0.002
T41 Poisoning by anaesthetics and therapeutic gases
0.002 0.998 0.000
D47.2 Monoclonal gammopathy
0.002 0.998 0.000
H25.9 Senile cataract, unspecified
0.000 0.998 0.002
T45.0 Antiallergic and antiemetic drugs
0.002 0.998 0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.002 0.998 0.000
Q21 Congenital malformations of cardiac septa
0.002 0.998 0.000
S32 Fracture of lumbar spine and pelvis
0.000 0.998 0.002
N71.9 Inflammatory disease of uterus, unspecified
0.000 0.998 0.002
N94 Pain and other conditions associated with female genital organs and menstrual cycle
0.000 0.998 0.002
M89.92 Disorder of bone, unspecified (Upper arm)
0.002 0.998 0.000
S32.10 Fracture of sacrum (closed)
0.000 0.998 0.002
F33.1 Recurrent depressive disorder, current episode moderate
0.002 0.998 0.000
G93.5 Compression of brain
0.000 0.998 0.002
G93.4 Encephalopathy, unspecified
0.000 0.998 0.002
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.002 0.998 0.000
S32.1 Fracture of sacrum
0.000 0.998 0.002
M51.2 Other specified intervertebral disk displacement
0.002 0.998 0.000
N30.2 Other chronic cystitis
0.000 0.998 0.002
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.002 0.998 0.000
T36 Poisoning by systemic antibiotics
0.002 0.998 0.000
M19.96 Arthrosis, unspecified-Lower leg
0.002 0.998 0.000
F33.8 Other recurrent depressive disorders
0.002 0.998 0.000
O35.9 Maternal care for (suspected) foetal abnormality and damage, unspecified
0.000 0.998 0.002
O35.0 Maternal care for (suspected) central nervous system malformation in foetus
0.000 0.998 0.002
T78.2 Anaphylactic shock, unspecified
0.002 0.998 0.000
T46 Poisoning by agents primarily affecting the cardiovascular system
0.002 0.998 0.000
H65.4 Other chronic nonsuppurative otitis media
0.000 0.998 0.002
C49.3 Connective and soft tissue of thorax
0.002 0.998 0.000
F33.0 Recurrent depressive disorder, current episode mild
0.002 0.998 0.000
G93.9 Disorder of brain, unspecified
0.000 0.998 0.002
M89.5 Osteolysis
0.002 0.998 0.000
Q23.0 Congenital stenosis of aortic valve
0.002 0.998 0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.002 0.998 0.000
T45.9 Primarily systemic and haematological agent, unspecified
0.002 0.998 0.000
T45.8 Other primarily systemic and haematological agents
0.002 0.998 0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.002 0.998 0.000
T45.6 Fibrinolysis-affecting drugs
0.002 0.998 0.000
T45.3 Enzymes, not elsewhere classified
0.002 0.998 0.000
T46.4 Angiotensin-converting-enzyme inhibitors
0.002 0.998 0.000
E86 Volume depletion
0.000 0.998 0.002
I15.2 Hypertension secondary to endocrine disorders
0.001 0.998 0.001
S32.8 Fracture of other and unspecified parts of lumbar spine and pelvis
0.000 0.998 0.002
T43.9 Psychotropic drug, unspecified
0.002 0.998 0.000
Z12.0 Special screening examination for neoplasm of stomach
0.000 0.998 0.002
I15.0 Renovascular hypertension
0.001 0.998 0.001
Q23.9 Congenital malformation of aortic and mitral valves, unspecified
0.002 0.998 0.000
Q23.8 Other congenital malformations of aortic and mitral valves
0.002 0.998 0.000
Q23.4 Hypoplastic left heart syndrome
0.002 0.998 0.000
Q23.2 Congenital mitral stenosis
0.002 0.998 0.000
T45.2 Vitamins, not elsewhere classified
0.002 0.998 0.000
M89 Other disorders of bone
0.002 0.998 0.000
Q24 Other congenital malformations of heart
0.002 0.998 0.000
H65.9 Nonsuppurative otitis media, unspecified
0.000 0.998 0.002
I15.8 Other secondary hypertension
0.001 0.998 0.001
T43.8 Other psychotropic drugs, not elsewhere classified
0.002 0.998 0.000
T45.1 Antineoplastic and immunosuppressive drugs
0.002 0.998 0.000
C49 Malignant neoplasm of other connective and soft tissue
0.002 0.998 0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.002 0.998 0.000
B98.0 Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters
0.002 0.998 0.000
F33.4 Recurrent depressive disorder, currently in remission
0.002 0.998 0.000
H16.0 Corneal ulcer
0.002 0.998 0.000
O35.7 Maternal care for (suspected) damage to foetus by other medical procedures
0.000 0.998 0.002
O35.6 Maternal care for (suspected) damage to foetus by radiation
0.000 0.998 0.002
O35.5 Maternal care for (suspected) damage to foetus by drugs
0.000 0.998 0.002
O35.4 Maternal care for (suspected) damage to foetus from alcohol
0.000 0.998 0.002
O35.3 Maternal care for (suspected) damage to foetus from viral disease in mother
0.000 0.998 0.002
Q21.0 Ventricular septal defect
0.002 0.998 0.000
Q24.9 Congenital malformation of the heart, unspecified
0.002 0.998 0.000
T45.4 Iron and its compounds
0.002 0.998 0.000
T48.5 Anti-common-cold drugs
0.002 0.998 0.000
C45-C49 Malignant neoplasms of mesothelial and soft tissue
0.002 0.998 0.000
Q20-Q28 Congenital malformations of the circulatory system
0.002 0.998 0.000
M89.93 Disorder of bone, unspecified (Forearm)
0.002 0.998 0.000
M89.91 Disorder of bone, unspecified (Shoulder region)
0.002 0.998 0.000
M90.7 Fracture of bone in neoplastic disease
0.002 0.998 0.000
O35.2 Maternal care for (suspected) hereditary disease in foetus
0.000 0.998 0.002
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.002 0.998 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.002 0.998 0.000
M89.99 Disorder of bone, unspecified (Site unspecified)
0.002 0.998 0.000
S32.80 Fracture of other and unspecified parts of lumbar spine and pelvis (closed)
0.000 0.998 0.002
Q21.9 Congenital malformation of cardiac septum, unspecified
0.002 0.998 0.000
E83 Disorders of mineral metabolism
0.000 0.998 0.002
M90.72 Fracture of bone in neoplastic disease (Upper arm)
0.002 0.998 0.000
O36.9 Maternal care for foetal problem, unspecified
0.000 0.998 0.002
Q23.3 Congenital mitral insufficiency
0.002 0.998 0.000
T40.5 Cocaine
0.002 0.998 0.000
T49.9 Topical agent, unspecified
0.002 0.998 0.000
T49.8 Other topical agents
0.002 0.998 0.000
T49.7 Dental drugs, topically applied
0.002 0.998 0.000
T49.6 Otorhinolaryngological drugs and preparations
0.002 0.998 0.000
T49.5 Ophthalmological drugs and preparations
0.002 0.998 0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.002 0.998 0.000
T49.3 Emollients, demulcents and protectants
0.002 0.998 0.000
T49.2 Local astringents and local detergents
0.002 0.998 0.000
T49.1 Antipruritics
0.002 0.998 0.000
X23.0 Home
0.000 0.998 0.002
Z08.8 Follow-up examination after other treatment for malignant neoplasm
0.000 0.998 0.002
Z48.9 Surgical follow-up care, unspecified
0.000 0.998 0.002
T78 Adverse effects, not elsewhere classified
0.002 0.998 0.000
M89.94 Disorder of bone, unspecified (Hand)
0.002 0.998 0.000
M89.90 Disorder of bone, unspecified (Multiple sites)
0.002 0.998 0.000
M90.75 Fracture of bone in neoplastic disease (Pelvic region and thigh)
0.002 0.998 0.000
S82.10 Fracture of upper end of tibia (closed)
0.000 0.998 0.002
I15.9 Seconday hypertension, unspecified
0.001 0.998 0.001
N94.9 Unspecified condition associated with female genital organs and menstrual cycle
0.000 0.998 0.002
S32.3 Fracture of ilium
0.000 0.998 0.002
T78.0 Anaphylactic shock due to adverse food reaction
0.002 0.998 0.000
H20.9 Iridocyclitis, unspecified
0.002 0.998 0.000
I44.2 Atrioventricular block, complete
0.002 0.998 0.000
N20.9 Urinary calculus, unspecified
0.002 0.998 0.000
T40.1 Heroin
0.002 0.998 0.000
T41.5 Therapeutic gases
0.001 0.998 0.000
T41.4 Anaesthetic, unspecified
0.001 0.998 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.